Majed Matar

1.0k total citations
21 papers, 626 citations indexed

About

Majed Matar is a scholar working on Molecular Biology, Immunology and Biotechnology. According to data from OpenAlex, Majed Matar has authored 21 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Immunology and 7 papers in Biotechnology. Recurrent topics in Majed Matar's work include Immunotherapy and Immune Responses (9 papers), RNA Interference and Gene Delivery (8 papers) and Cancer Research and Treatments (6 papers). Majed Matar is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), RNA Interference and Gene Delivery (8 papers) and Cancer Research and Treatments (6 papers). Majed Matar collaborates with scholars based in United States, United Kingdom and France. Majed Matar's co-authors include Jason G. Fewell, Federica Pericle, Sanjeev Kumar Mendiratta, Khursheed Anwer, Jeffrey L. Nordstrom, Abraham Quezada, William T. Gerthoffer, Jared M. McLendon, Danny Lewis and Masahiko Oka and has published in prestigious journals such as The FASEB Journal, Journal of Controlled Release and Vaccine.

In The Last Decade

Majed Matar

20 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Majed Matar United States 14 331 213 134 118 100 21 626
Fangcen Liu China 9 155 0.5× 191 0.9× 182 1.4× 90 0.8× 71 0.7× 18 518
E Satoh Japan 9 241 0.7× 96 0.5× 112 0.8× 165 1.4× 87 0.9× 12 487
Lorena Alba‐Castellón Spain 16 426 1.3× 181 0.8× 245 1.8× 33 0.3× 52 0.5× 30 703
Gregory J. Duigou United States 11 279 0.8× 142 0.7× 162 1.2× 131 1.1× 50 0.5× 22 528
Ann Brun Sweden 15 522 1.6× 172 0.8× 108 0.8× 158 1.3× 32 0.3× 25 815
Alexander C. James Australia 10 302 0.9× 62 0.3× 101 0.8× 51 0.4× 31 0.3× 15 531
Changlin Yang United States 13 229 0.7× 295 1.4× 263 2.0× 33 0.3× 91 0.9× 46 660
Ann Hanna United States 10 531 1.6× 172 0.8× 155 1.2× 58 0.5× 49 0.5× 16 718
Yuan‐Tong Liu China 14 319 1.0× 365 1.7× 384 2.9× 43 0.4× 146 1.5× 18 894
Stefania Forti Italy 9 232 0.7× 85 0.4× 139 1.0× 77 0.7× 37 0.4× 10 523

Countries citing papers authored by Majed Matar

Since Specialization
Citations

This map shows the geographic impact of Majed Matar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Majed Matar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Majed Matar more than expected).

Fields of papers citing papers by Majed Matar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Majed Matar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Majed Matar. The network helps show where Majed Matar may publish in the future.

Co-authorship network of co-authors of Majed Matar

This figure shows the co-authorship network connecting the top 25 collaborators of Majed Matar. A scholar is included among the top collaborators of Majed Matar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Majed Matar. Majed Matar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sood, Subeena, Majed Matar, Kempaiah Rayavara, et al.. (2024). Strong immunogenicity & protection in mice with PlaCCine: A COVID-19 DNA vaccine formulated with a functional polymer. Vaccine. 42(6). 1300–1310.
2.
Ramelli, Sabrina, Brian S. Comer, Jared M. McLendon, et al.. (2020). Nanoparticle Delivery of Anti-inflammatory LNA Oligonucleotides Prevents Airway Inflammation in a HDM Model of Asthma. Molecular Therapy — Nucleic Acids. 19. 1000–1014. 17 indexed citations
3.
4.
McLendon, Jared M., Sachindra Raj Joshi, Majed Matar, et al.. (2015). Lipid nanoparticle delivery of a microRNA-145 inhibitor improves experimental pulmonary hypertension. Journal of Controlled Release. 210. 67–75. 91 indexed citations
5.
Prabhakarpandian, Balabhaskar, et al.. (2015). Synthetic tumor networks for screening drug delivery systems. Journal of Controlled Release. 201. 49–55. 47 indexed citations
6.
Matar, Majed, et al.. (2011). Versatile cationic lipids for siRNA delivery. Journal of Controlled Release. 158(2). 269–276. 34 indexed citations
7.
Polach, Kevin J., Majed Matar, Angela Rea-Ramsey, et al.. (2011). Delivery of siRNA to the Mouse Lung via a Functionalized Lipopolyamine. Molecular Therapy. 20(1). 91–100. 37 indexed citations
8.
Fewell, Jason G., et al.. (2009). Treatment of disseminated ovarian cancer using nonviral interleukin‐12 gene therapy delivered intraperitoneally. The Journal of Gene Medicine. 11(8). 718–728. 42 indexed citations
9.
Sonabend, Adam M., Ilya V. Ulasov, Yu Han, et al.. (2008). A safety and efficacy study of local delivery of interleukin-12 transgene by PPC polymer in a model of experimental glioma. Anti-Cancer Drugs. 19(2). 133–142. 26 indexed citations
10.
11.
12.
Matar, Majed, et al.. (2006). Synthesis and Characterization of Low Molecular Weight Linear Polyethylenimines for Gene Delivery. Journal of Biomedical Nanotechnology. 2(1). 53–61. 5 indexed citations
13.
Fewell, Jason G., et al.. (2005). Synthesis and application of a non-viral gene delivery system for immunogene therapy of cancer. Journal of Controlled Release. 109(1-3). 288–298. 45 indexed citations
14.
Mendiratta, Sanjeev Kumar, et al.. (2001). Therapeutic tumor immunity induced by polyimmunization with melanoma antigens gp100 and TRP-2.. PubMed. 61(3). 859–63. 57 indexed citations
15.
Matar, Majed, et al.. (2000). Antitumoral effect of a nonviral interleukin-2 gene therapy is enhanced by combination with 5-fluorouracil. Cancer Gene Therapy. 7(8). 1165–1171. 7 indexed citations
16.
Mendiratta, Sanjeev Kumar, et al.. (2000). Combination of Interleukin 12 and Interferon α Gene Therapy Induces a Synergistic Antitumor Response against Colon and Renal Cell Carcinoma. Human Gene Therapy. 11(13). 1851–1862. 31 indexed citations
17.
Blezinger, Paul, Guoyong Yin, Liang Xie, et al.. (1999). Intravenous delivery of an endostatin gene complexed in cationic lipid inhibits systemic angiogenesis and tumor growth in murine models. Angiogenesis. 3(3). 205–210. 11 indexed citations
18.
Mendiratta, Sanjeev Kumar, Abraham Quezada, Majed Matar, et al.. (1999). Intratumoral delivery of IL-12 gene by polyvinyl polymeric vector system to murine renal and colon carcinoma results in potent antitumor immunity. Gene Therapy. 6(5). 833–839. 59 indexed citations
19.
Blezinger, Paul, Bruce Freimark, Majed Matar, et al.. (1999). Intratracheal Administration of Interleukin 12 Plasmid-Cationic Lipid Complexes Inhibits Murine Lung Metastases. Human Gene Therapy. 10(5). 723–731. 40 indexed citations
20.
Coleman, Michael D., Susanne Müller, Abraham Quezada, et al.. (1998). Nonviral Interferon α Gene Therapy Inhibits Growth of Established Tumors by Eliciting a Systemic Immune Response. Human Gene Therapy. 9(15). 2223–2230. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fangcen Liu Breakdown of academic impact, for papers by E Satoh Breakdown of academic impact, for papers by Lorena Alba‐Castellón Breakdown of academic impact, for papers by Gregory J. Duigou Breakdown of academic impact, for papers by Ann Brun Breakdown of academic impact, for papers by Alexander C. James Breakdown of academic impact, for papers by Changlin Yang Breakdown of academic impact, for papers by Ann Hanna Breakdown of academic impact, for papers by Yuan‐Tong Liu Breakdown of academic impact, for papers by Stefania Forti
Rankless by CCL
2026